Table 3.
In silico Pharmacokinetic Analysis: Absorption, Distribution, Metabolism, Excretion and Toxicity of FA2 and Acarbose
| Properties | Compounds | Acarbose | FA2 |
|---|---|---|---|
| Absorption | Water solubility | Soluble | Moderate |
| P-glycoprotein substrate | No | No | |
| Log Kp (skin permeation) cm/s | -16.29 | -6.40 | |
| Blood-Brain Barrier | No | No | |
| Gastro- Intestinal Absorption | Low | High | |
| Distribution | Subcellular localization | Mitochondria | Mitochondria |
| Metabolism | CYP 3A2 Inhibitor | No | No |
| CYP 2C9 Inhibitor | No | Yes | |
| CYP 2D6 Inhibitor | No | No | |
| CYP 2C19 Inhibitor | No | Yes | |
| CYP 3A4 Inhibitor | No | No | |
| Excretion | Renal OCT2 substrate | No | No |
| Toxicity | Rat acute toxicity (LD50,mol/kg) | 1.46 | 2.515 |
| Oral Toxicity classification | VI | III | |
| Ames toxicity | No | No |